Clinical and Echocardiographic Features of Mitral Annular Calcium in Patients Aged ≤50 Years

Adaya Weissler-Snir1, Daniel Weisenberg1, Sharon Natanzon1

  • 1Department of Cardiology, Rabin Medical Center, Beilinson Hospital, Petah-Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Insights

Mitral annular calcification (MAC) in patients under 50 is linked to higher rates of cardiovascular disease, kidney disease, and aortic valve issues. This finding suggests MAC in young individuals signals broader atherosclerotic disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Valvular Heart Disease

Background:

  • Data on mitral annular calcification (MAC) in young patients (<50 years) and associated cardiovascular risks are limited.
  • Understanding these associations is crucial for early detection and management in this demographic.

Purpose of the Study:

  • To characterize young patients (<50 years) diagnosed with MAC.
  • To investigate the association of MAC with cardiovascular risk factors and comorbidities in this population.

Main Methods:

  • Prospective enrollment of patients undergoing echocardiography into a database.
  • Inclusion of 56 patients aged <50 years with MAC, analyzing clinical, laboratory, and echocardiographic data.

Main Results:

  • High prevalence of cardiovascular risk factors (hypertension 53%, diabetes 30%, dyslipidemia 43%, smoking 39%) and established cardiovascular disease (CAD 39%, stroke 19%) in young MAC patients.
  • Significant comorbidity with chronic kidney disease (52%), including end-stage renal disease (30%) and renal transplantation (11%).
  • Frequent co-occurrence of mitral regurgitation (25%), aortic valve disease (66%), left ventricular hypertrophy (56%), and dysfunction (16%).

Conclusions:

  • MAC in young patients serves as a significant marker for underlying atherosclerotic disease.
  • The presence of MAC in younger individuals is strongly associated with chronic kidney disease.
  • MAC in this age group also indicates a high likelihood of coexisting aortic valve disease.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
459
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
811
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
913
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
935